Bio Green Med Solution, Inc. (BGMS) vs Xenetic Biosciences, Inc. (XBIO)

Bio Green Med Solution, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Bio Green Med Solution, Inc. and Xenetic Biosciences, Inc. are of similar size ($6.2M and $5.8M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against 33.3%. Xenetic Biosciences, Inc. has the higher net margin (−75.9% vs −715.5%) and the higher return on invested capital (0.00% vs −67.3%). Across the 17 metrics below, Xenetic Biosciences, Inc. leads on 10 and Bio Green Med Solution, Inc. on 7.

Valuation

Metric BGMS XBIO Biotechnology median
P/E n/m n/m 7.88
P/S 2.77 1.67 11.47
P/B 0.72 0.90 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.39 0.74
EV/Sales 0.73 (0.31) 10.73
Earnings yield (395.65%) (48.95%) (28.84%)
Free cash flow yield (19.45%) (42.50%) (23.03%)

Profitability

Metric BGMS XBIO Biotechnology median
Gross margin 19.34% 100.00% 65.16%
Operating margin (194.95%) (81.01%) 0.00%
Net margin (715.48%) (75.90%) 0.00%
Free cash flow margin (59.00%) (70.93%) 0.00%
Return on equity (246.85%) (47.05%) (57.72%)
Return on assets (217.30%) (40.17%) (49.22%)
Return on invested capital (67.28%) 0.00% 0.00%

Growth

Metric BGMS XBIO Biotechnology median
Revenue growth (TTM) 2,414.86% 33.30% 5.64%
EPS growth (last fiscal year) 98.71% 38.52% —
Revenue growth, 5-year CAGR (17.41%) 46.78% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGMS XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.63 7.43 4.73
Net debt to EBITDA 0.42 2.78 0.96

Dividend

Metric BGMS XBIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BGMS XBIO Biotechnology median
Market cap 6.16m 5.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack